Edward V Loftus
Loftus, Edward V.
Loftus, Edward V. Jr
VIAF ID: 315218595 (Personal)
Permalink: http://viaf.org/viaf/315218595
Preferred Forms
-
100 0 _
‡a
Edward V Loftus
-
100 1 _
‡a
Loftus, Edward V.
-
100 1 _ ‡a Loftus, Edward V.
-
100 1 _
‡a
Loftus, Edward V.
‡c
Jr
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| Leczenie farmakologiczne choroby Leśniowskiego-Crohna |
|
| The Mayo Foundation presents, 1999: |
|
| Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab |
|
| Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. |
|
| Outcomes of Endoscopic Therapy for Luminal Strictures in Crohn's Disease |
|
| Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study |
|
| Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease |
|
| Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease |
|
| Portal hypertension vasculopathy--the small intestine, too? |
|
| Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations |
|
| Potential Pitfalls When Assessing the Impact of Cytomegalovirus in Inflammatory Bowel Disease |
|
| A practical perspective on ulcerative colitis: patients' needs from aminosalicylate therapies |
|
| Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study |
|
| Predictors of Durability of Radiological Response in Patients With Small Bowel Crohn's Disease. |
|
| Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography. |
|
| Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. |
|
| Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis |
|
| Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein |
|
| Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States |
|
| Rate and Predictors of Interval Esophageal and Gastric Cancers after Esophagogastroduodenoscopy in the United States |
|
| Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease |
|
| Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. |
|
| Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial |
|
| Reply: To PMID 23978350 |
|
| Reply to Soteriadou et al |
|
| Response to Chamberlin and Borody |
|
| Response to: Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy |
|
| Response to 'Preoperative Vedolizumab and Postoperative Outcomes in Inflammatory Bowel Disease: Does Smoke Always Mean Fire?' |
|
| Response to Ribaldone |
|
| Response to Stormont et al |
|
| Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis |
|
| Retained Capsule Endoscopy in a Large Tertiary Care Academic Practice and Radiologic Predictors of Retention. |
|
| Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease. |
|
| A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease. |
|
| Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease |
|
| Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis |
|
| Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort |
|
| Risk of cancer in inflammatory bowel disease: going up, going down, or still the same? |
|
| Risk of colorectal cancer after colonoscopy compared with flexible sigmoidoscopy or no lower endoscopy among older patients in the United States, 1998-2005 |
|
| Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation |
|
| Risk of de-novo inflammatory bowel disease among obese patients treated with bariatric surgery or weight loss medications |
|
| Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort. |
|
| Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. |
|
| Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials |
|
| Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease |
|
| Safety of TNF-α inhibitors during IBD pregnancy: a systematic review |
|
| Safety profile of IBD therapeutics: infectious risks |
|
| Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. |
|
| Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries |
|
| Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index. |
|
| Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis |
|
| Similar outcomes of surgical and medical treatment of intra-abdominal abscesses in patients with Crohn's disease |
|
| Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. |
|
| Small intestinal adenocarcinoma in Crohn's disease: a case-control study |
|
| Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease |
|
| Successful management of Crohn's disease of the ileoanal pouch with infliximab |
|
| Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004) |
|
| Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. |
|
| Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1 |
|
| Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a prospective study. |
|
| Systematic review: colitis associated with anti-CTLA-4 therapy. |
|
| Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis |
|
| Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease |
|
| Technology Insight: new techniques for imaging the gut in patients with IBD. |
|
